2021
DOI: 10.1002/ardp.202100200
|View full text |Cite
|
Sign up to set email alerts
|

Developing a scaffold for urease inhibition based on benzothiazoles: Synthesis, docking analysis, and therapeutic potential

Abstract: The synthesis, in silico molecular docking, and in vitro urease inhibition studies of a novel series of benzothiazole derivatives are reported. The title compounds in the two series, namely, 2-({5-[(benzothiazol-2-ylthio)methyl]-1,3,4-oxadiazol-2-yl}thio)-1-(4-substitutedphenyl)ethan-1-one and 2-(benzothiazol-2-ylthio)-1-(4-substituted-phenyl)ethan-1-one oxime, were synthesized by the reaction of benzo[d]thiazole-2-thiol with different kinds of intermediates in several steps using both conventional and microwa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 46 publications
0
10
0
Order By: Relevance
“…8c Further transformation of 3r with hydroxylamine led to 73% yield of oxime derivative 5 (Scheme 4c). 14 To gain insights into alkylation process, an isotopic labeling experiment was carried out with the deuterated sulfhydryl benzoxazole 1d-D as the substrate, 15 indicating that proton transfer was achieved from sulfhydryl benzoxazole and TfOH (Scheme 5a). For a comprehensive understanding of reactions, a survey of control experiments was carried out to gain more insights into the catalytic system.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…8c Further transformation of 3r with hydroxylamine led to 73% yield of oxime derivative 5 (Scheme 4c). 14 To gain insights into alkylation process, an isotopic labeling experiment was carried out with the deuterated sulfhydryl benzoxazole 1d-D as the substrate, 15 indicating that proton transfer was achieved from sulfhydryl benzoxazole and TfOH (Scheme 5a). For a comprehensive understanding of reactions, a survey of control experiments was carried out to gain more insights into the catalytic system.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…Jack bean urease inhibitory activity and kinetic studies on the synthesized compounds and thiourea were examined based on previously published studies. 14,[27][28][29][30] Thiourea (Sigma-Aldrich) was used as the standard inhibitor. The urease inhibition percentage was calculated as follows where OD control is the activity of the enzyme without the compound/standard and OD compound is the activity of the enzyme with the compound/standard at different concentrations.…”
Section: In Vitro Urease Inhibition Assay and Kinetic Studiesmentioning
confidence: 99%
“…Jack bean urease inhibitory activity and kinetic studies on the synthesized compounds and thiourea were examined based on previously published studies. 14,2730 Thiourea (Sigma-Aldrich) was used as the standard inhibitor. The urease inhibition percentage was calculated as follows…”
Section: In Vitro Urease Inhibition Assay and Kinetic Studiesmentioning
confidence: 99%
“…Pyrido [2,3-d]pyrimidine ring systems have assorted biological and pharmacological activities such as being analgesic, anti-inflammatory [1-3], antitubercular [4], antimicrobial [5][6][7], a threonine tyrosine kinase (TTK) inhibitor [8], an adenosine kinase inhibitor [9], antiviral [10], antioxidant [11][12][13][14], a dihydrofolate reductase inhibitor [15,16], and an efficient glucosidase inhibitor [17,18]. Moreover, the 1,3-benzothiazole nucleus is a highly significant scaffold in the drug design, due to important pharmacological and medicinal activities, such as being antiviral [19], antituberculosis [20], an identifier of selective CB2 receptor ligands [21], antitumor [22][23][24], antimicrobial [25][26][27], anticonvulsant [28], a schistosome BCL-2 inhibitor [29], antidiabetic [30], antioxidant [31], an anti-Alzheimer drug [32] and a urease inhibitor [33] among the heterocyclic compounds containing a pyrimidine and benzothiazole nucleus that exhibits biological activity [34][35][36] (Figure 1). kinase (TTK) inhibitor [8], an adenosine kinase inhibitor [9], antiviral [10], antioxidant [11][12][13]…”
Section: Introductionmentioning
confidence: 99%
“…kinase (TTK) inhibitor [8], an adenosine kinase inhibitor [9], antiviral [10], antioxidant [11][12][13][14], a dihydrofolate reductase inhibitor [15,16], and an efficient glucosidase inhibitor [17,18]. Moreover, the 1,3-benzothiazole nucleus is a highly significant scaffold in the drug design, due to important pharmacological and medicinal activities, such as being antiviral [19], antituberculosis [20], an identifier of selective CB2 receptor ligands [21], antitumor [22][23][24], antimicrobial [25][26][27], anticonvulsant [28], a schistosome BCL-2 inhibitor [29], antidiabetic [30], antioxidant [31], an anti-Alzheimer drug [32] and a urease inhibitor [33] among the heterocyclic compounds containing a pyrimidine and benzothiazole nucleus that exhibits biological activity [34][35][36] (Figure 1). Accordingly, with all of the previous observations of the biological importance and in continuation of our program in the synthesis of pyrido [2,3-d]pyrimidine [37], this study aims to design and develop highly selective and efficacious antimicrobial and anticancer agents of a novel series of pyrido [2,3-d]pyrimidine derivatives bearing different heterocyclic and aryl moieties such as benzothiazole, thiophene, furan, piperonal, naphthalene, and fluorophenyl as a side chain and various aryl derivatives by the microwave irradiation technique.…”
Section: Introductionmentioning
confidence: 99%